144 ·Filed May 18, 2026

ARTV

Artiva Biotherapeutics, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed4mo ago SEC0001621152-26-000003
Form 144 — notice of proposed sale of securities
Actionable Insight • Neutral

This is a routine sell-to-cover transaction for tax withholding upon RSU vesting, not a discretionary insider sale. No bearish signal. Monitor for any subsequent open-market selling by insiders, which would be more informative. No trading action warranted.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d ⚠ clustered
ARTV ▲ +32.16% at T+60d
NEUTRAL call ✓ call won +32.16% · α vs SPY +25.87% · entry $8.55 → $11.30
Entry anchored
May 18, 2026
via day open
T+1d
-8.30%
call -8.30% · α -9.34%
$7.84
settled 5mo ago
T+5d
-10.76%
call -10.76% · α -13.06%
$7.63
settled 4mo ago
T+20d
+16.26%
call +16.26% · α +15.27%
$9.94
settled 4mo ago
T+60d
+32.16%
call +32.16% · α +25.87%
$11.30
settled 7w ago

Price Chart

Loading chart...

Executive Summary

Jennifer Bush, an officer and director of Artiva Biotherapeutics, filed a Form 144 to sell 9,000 shares of common stock as a sell-to-cover transaction for taxes owed on recently vested restricted stock units. At current market cap of ~$242M, this is a small, routine transaction with no material fundamental signal.

Key Facts

  • Jennifer Bush (Officer/Director) filed Form 144 on 5/18/2026 proposing to sell 9,000 shares of Artiva Biotherapeutics (ARTV).
  • The sale is explicitly a 'sell-to-cover transaction for taxes owed related to recent vesting of stock unit awards' — not a discretionary open-market sale.
  • Total estimated proceeds from the sale are immaterial relative to the company's ~$242M market cap.
  • The shares were acquired via vesting of restricted stock units on 5/15/2026 as compensation for services.

Financial Impact

9,000 shares at ~$27/share implied by $242M market cap over ~9M shares outstanding is approximately $243K — a de minimis amount.

insider holdingsdilution

Risk Factors

  • Lock-up or quiet-period implications not disclosed — general SEC Rule 144 requirements apply.
  • If the company enters a material event window (earnings, data readout), this pre-scheduled tax sale could appear poorly timed, but the filing explicitly attributes it to tax obligations.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
92% bullish (12 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001621152-26-000003
Document: 0001621152-26-000003-index.html0001621152-26-000003
Document: 0001621152-26-000003.txt0001621152-26-000003
28 reports for ARTV
Performance horizon
88% Hit rate 14 of 16 directional calls best @ T+20▲ +38.82%Jun 8, 2026
Filters
Rows
Reports for ARTV — sortable, filterable
TypeNow
Sep 11, 2026
20d ago
8-K
NEUTRAL ★ 3/10
$10.14 $8.91▼ −12.13%▼ −11.67%$6.86 (−32.35%)
Sep 9, 2026
23d ago
Insider Cluster
NEUTRAL ★ 4/10
$10.79 $10.42▼ −3.43%▼ −2.83%$6.86 (−36.42%)
Sep 9, 2026
23d ago
Insider Cluster
NEUTRAL ★ 3/10
$10.79 $10.42▼ −3.43%▼ −2.83%$6.86 (−36.42%)
Sep 9, 2026
23d ago
Insider Cluster
NEUTRAL ★ 4/10
$10.79 $10.42▼ −3.43%▼ −2.83%$6.86 (−36.42%)
Sep 9, 2026
23d ago
Insider Cluster
NEUTRAL ★ 3/10
$10.79 $10.42▼ −3.43%▼ −2.83%$6.86 (−36.42%)
Sep 9, 2026
23d ago
Insider Cluster
BEARISH ★ 5/10
$10.79 $10.42▲ +3.43%▲ +2.83%$6.86 (+36.42%)
Sep 4, 2026
28d ago
Insider Cluster
NEUTRAL ★ 2/10
$11.19 $10.88▼ −2.77%▼ −2.22%$6.86 (−38.70%)
Aug 15, 2026
6w ago
Institutional Cluster
BULLISH ★ 6/10
$11.74 $11.68▼ −0.51%▲ +0.16%$6.86 (−41.57%)
Jul 31, 2026
8w ago
Insider Buy
BULLISH ★ 7/10
$10.76 $11.07▲ +2.88%▲ +1.08%$6.86 (−36.25%)
Jul 28, 2026
9w ago
Insider Buy
BULLISH ★ 6/10
$10.53 $10.02▼ −4.84%▼ −3.30%$6.86 (−34.85%)
Showing 10 of 28

US Market Status

Market Open — Closes in 3h 41m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access